LINC01278 Gene

Name long intergenic non-protein coding RNA 1278
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Long non‐coding RNA LINC01278 exhibits context‐dependent roles in human diseases and displays diverse regulatory mechanisms. In colorectal cancer, LINC01278 is upregulated and promotes tumor progression by sponging miR‐134, thereby releasing repression of KDM2A and enhancing cell viability, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In vascular smooth muscle cells during aortic dissection, in contrast, LINC01278 is downregulated; its overexpression attenuates phenotypic switching by binding miR‐500b‐5p to regulate ACTG2 expression, suggesting a protective role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In papillary thyroid carcinoma, LINC01278 is downregulated and functions as a tumor suppressor. It acts as a competing endogenous RNA (ceRNA) by sequestering miR‐376c‐3p to positively regulate DNM3 expression, thereby inhibiting proliferation and metastasis and modulating the epithelial–mesenchymal transition. In addition, LINC01278 is transcriptionally activated by the β‐catenin/LEF‐1 complex and in turn promotes β‐catenin ubiquitination and degradation, establishing a negative feedback loop on Wnt/β‐catenin signaling."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In laryngeal cancer, LINC01278 plays an oncogenic role by suppressing miR‐185‐5p, which results in enhanced expression of CST1 and subsequent stimulation of proliferation, migration, and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In hepatocellular carcinoma, a β‐catenin/TCF‐4–LINC01278–miR‐1258–Smad2/3 feedback loop contributes to metastasis, with LINC01278 acting as a negative regulator of miR‐1258 to ultimately facilitate TGF‐β/Smad signaling and cell dissemination."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In osteosarcoma, LINC01278 is overexpressed and associated with poor prognosis. It promotes tumor growth by acting as a ceRNA: one study demonstrates that LINC01278 modulates the miR‐134‐5p/KRAS axis, while another shows that it sponges miR‐133a‐3p to release PTHR1, thereby enhancing proliferation and inhibiting apoptosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Beyond these mechanistic insights, LINC01278 has also been identified as part of RNA signatures with diagnostic and prognostic potential. It has been incorporated into ceRNA regulatory networks in type 1 diabetes mellitus"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "and as a component of an eight‐lncRNA prognostic signature in childhood acute lymphoblastic leukemia."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these findings highlight the multifaceted functions of LINC01278 in regulating cell proliferation, differentiation, and metastasis. Its role, either as an oncogene or tumor suppressor, is highly dependent on the cellular context, underscoring its promise as a potential therapeutic target and biomarker in various clinical settings.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "C Xi, N-Y Ye, Y-B Wang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA LINC01278 accelerates colorectal cancer progression via miR-134-5p/KDM2A axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202010_23405"}], "href": "https://doi.org/10.26355/eurrev_202010_23405"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33155208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33155208"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Weitie Wang, Qing Liu, Yong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC01278 Sponges miR-500b-5p to Regulate the Expression of ACTG2 to Control Phenotypic Switching in Human Vascular Smooth Muscle Cells During Aortic Dissection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Heart Assoc (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/JAHA.120.018062"}], "href": "https://doi.org/10.1161/JAHA.120.018062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33910387"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33910387"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shaojian Lin, Langping Tan, Dingyuan Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Manag Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/CMAR.S217886"}], "href": "https://doi.org/10.2147/CMAR.S217886"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31572010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31572010"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shaojian Lin, Weiwei Zhang, Ziwen Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "β-Catenin/LEF-1 transcription complex is responsible for the transcriptional activation of LINC01278."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell Int (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12935-021-02082-9"}], "href": "https://doi.org/10.1186/s12935-021-02082-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34273985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34273985"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Bin Shen, Haibin Ding, Yanyan Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of the Long Intergenic Non-Protein-Coding RNA 1278/miR-185-5p/Cystatin SN Axis in Laryngeal Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/6406943"}], "href": "https://doi.org/10.1155/2022/6406943"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35498540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35498540"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wei-Juan Huang, Xiao-Peng Tian, Si-Xue Bi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-020-1307-3"}], "href": "https://doi.org/10.1038/s41388-020-1307-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32372060"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32372060"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Guo-Feng Zhang, Bai-Sui Zhou, Xiao-Chun An, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC01278 is Highly Expressed in Osteosarcoma and Participates in the Development of Tumors by Mediating the miR-134-5p/KRAS Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Onco Targets Ther (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/OTT.S265591"}], "href": "https://doi.org/10.2147/OTT.S265591"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33531816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33531816"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Zhigang Qu, Shenglong Li "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA LINC01278 favors the progression of osteosarcoma via modulating miR-133a-3p/PTHR1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.29582"}], "href": "https://doi.org/10.1002/jcp.29582"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31994731"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31994731"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Qinghong Shi, Hanxin Yao "}, {"type": "b", "children": [{"type": "t", "text": "Signature RNAS and related regulatory roles in type 1 diabetes mellitus based on competing endogenous RNA regulatory network analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Med Genomics (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12920-021-00931-0"}], "href": "https://doi.org/10.1186/s12920-021-00931-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34006268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34006268"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Zhang Chen, Fan Yang, Hui Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a nomogram based on an 8-lncRNA signature as a novel diagnostic biomarker for childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.203116"}], "href": "https://doi.org/10.18632/aging.203116"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34106877"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34106877"}]}]}]}
NCBI Gene ID 92249
API
Download Associations
Predicted Functions View LINC01278's ARCHS4 Predicted Functions.
Co-expressed Genes View LINC01278's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View LINC01278's ARCHS4 Predicted Functions.

Functional Associations

LINC01278 has 902 functional associations with biological entities spanning 3 categories (chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.

Click the + buttons to view associations for LINC01278 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of LINC01278 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of LINC01278 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of LINC01278 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of LINC01278 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of LINC01278 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of LINC01278 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of LINC01278 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of LINC01278 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of LINC01278 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.